In VivoBiopharma Acquisitions Biopharma merger and acquisition value for the second quarter of 2022 reached $25.4bn from 36 transactions, 20 of which had disclosed values. Four M&A transactions hit or exceed
Medtech InsightIsraeli acute heart failure (HF) therapy firm Magenta Medical Ltd. has bulked up its coffers with an additional $15m, following a Series B financing that brought in new investors from Japan and th
Medtech InsightThe global market continues to be dominated by the three heavyweights Medtronic PLC , Boston Scientific Corp. and St. Jude Medical Inc. (bought by Abbott Laboratories Inc. , now Johnso
ScripIN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca